Sign in

Melinda Brown

Director at PRECISION BIOSCIENCES
Board

About Melinda Brown

Melinda Brown, age 68, has served on the DTIL Board since May 2022 and is Chair of the Audit Committee. She is a CPA with deep leadership experience in accounting, finance, and enterprise risk management, including roles at Tapestry, Inc. (SVP & Controller, 2012–2019) and 30 years at PepsiCo culminating as SVP, Global Financial Shared Services & Productivity; she holds a BS in Accounting and an MBA from the University of Connecticut and began her career at Coopers & Lybrand and the Financial Accounting Standards Board .

Past Roles

OrganizationRoleTenureCommittees/Impact
Tapestry, Inc.SVP & Controller2012–2019Led global control, supported brand acquisitions/integration and SAP implementation
PepsiCo, Inc.SVP, Global Financial Shared Services & Productivity30 years (most recent role)Led shared services, global finance outsourcing strategy, multi‑year productivity programs
Coopers & Lybrand; FASBEarly careerNot disclosedFoundational accounting experience

External Roles

OrganizationRoleTenureCommittees/Impact
University of Connecticut FoundationChair Emeritus; prior Audit ChairNot disclosedServed on Executive and Finance committees
AICPA; CT Society of CPAsMemberNot disclosedProfessional affiliations

Board Governance

  • Independence: The Board determined Melinda Brown is independent under Nasdaq rules (one of five independent directors) .
  • Committee assignments: Audit Committee Chair; not listed as a member of Compensation, Nominating & Governance, or Science & Technology committees .
  • Financial expertise: The Board determined Brown qualifies as an “audit committee financial expert” (Item 407(d)(5) of Regulation S‑K) .
  • Attendance and engagement: In 2024, Board met 7x; Audit 4x; Compensation 3x; Nominating 2x; Science & Tech 6x. Each incumbent director attended at least 75% of Board and applicable committee meetings; all directors attended the 2024 annual meeting .
  • Audit Committee report: Brown signed the 2024 Audit Committee Report recommending inclusion of audited financials in the 10‑K .
  • Board class reclassification: On March 4, 2025, Brown was reclassified from Class III to Class I (immediate reappointment). For all other purposes, including committee service and compensation, her service is deemed uninterrupted .

Committee Matrix (current as disclosed)

DirectorAuditCompensationNominating & GovernanceScience & Technology
Melinda BrownChair
Kevin J. BuehlerMember Member
Stanley R. Frankel, M.D.Chair
Geno GermanoMember Chair Member
Shari Lisa PiréMember Chair

Fixed Compensation

2024 Director CompensationFees Earned ($)Stock Awards ($)Total ($)
Melinda Brown55,000 129,998 184,998

Non‑Employee Director Compensation Policy specifics:

  • Annual director cash fees: Chair of Board $72,500; other directors $40,000; committee chairs/members fees: Audit Chair $15,000; Audit member $7,500; Compensation Chair $12,250; Compensation member $6,000; Science & Tech Chair $12,250; Science & Tech member $6,000; Nominating Chair $8,250; Nominating member $4,500. Paid quarterly in arrears, prorated for partial service .
  • Equity grants: Annual RSUs determined by board‑set aggregate value/FMV at grant; initial director grants may be options or RSUs; annual director RSUs vest in a single installment on the earlier of the day before the next annual meeting or first anniversary; initial RSUs vest in 12 substantially equal quarterly installments; options vest monthly over 36 months. All unvested options/RSUs vest in full upon a change in control .

Performance Compensation

  • Director equity is time‑based (RSUs/options) with no disclosed performance metrics for non‑employee directors. No director performance scorecards or TSR/EBITDA targets are disclosed for director equity grants .
Performance Metrics for Director PayDisclosed?
TSR/relative TSRNot disclosed
Revenue/EBITDA goalsNot disclosed
ESG metricsNot disclosed

Other Directorships & Interlocks

  • Public company boards: None disclosed for Brown in the DTIL proxy’s biography section .
  • Notable external board: University of Connecticut Foundation (Chair Emeritus; prior Audit Chair) .
  • Interlocks/relationships: Compensation consultant Aon engaged by the Compensation Committee; a subsidiary of Aon also served as broker for D&O insurance (fees: $45,442 for comp consulting; $225,000 for D&O brokerage in 2024). The Compensation Committee evaluated independence and determined no conflict; D&O brokerage engagement was recommended by management and approved by the Board .

Expertise & Qualifications

  • CPA; audit and financial literacy (audit committee financial expert) .
  • Enterprise risk management leadership at large public companies (PepsiCo; Tapestry) .
  • M&A integration and ERP/SAP implementation experience .
  • Governance: Prior audit committee chair at UConn Foundation .

Equity Ownership

Measure (as of March 20, 2025)Quantity% Outstanding
Beneficial ownership (total)19,425 shares <1%
Breakdown: Common shares7,218
Breakdown: Options exercisable within 60 days12,207
RSUs vesting within 60 daysNot disclosed for Brown
Shares outstanding basis10,481,931 shares

Director outstanding awards at 12/31/2024:

InstrumentVestedUnvested
Stock options (#)10,812 1,744
RSUs (# not vested)9,826

Ownership alignment policies:

  • Corporate Governance Guidelines address stock ownership for directors (no numeric multiple disclosed in proxy); guidelines posted on company website .
  • Anti‑hedging: Directors are prohibited from hedging DTIL securities (e.g., prepaid variable forwards, equity swaps, collars, exchange funds) .

Insider Trades and Section 16(a) Compliance

Item2024 StatusNotes
Section 16(a) filingsAll timely except delayed Form 4s for certain executives; Brown not listed among exceptions
Form 4 transaction detailsNot disclosed for Brown in proxy; insider‑trades data tool unavailable during this analysisAttempted Form 4 fetch failed due to authorization error (tool) [insider-trades SKILL.md; run error]. See Section 16(a) disclosure .

Governance Assessment

  • Strengths:

    • Independent Audit Chair with audit committee financial expert designation; robust audit committee remit including related‑party transaction oversight, ICFR, cybersecurity risk, and ESG matters tied to financials .
    • Attendance: Incumbent directors met ≥75% threshold; full attendance at the annual meeting, supporting engagement .
    • Anti‑hedging policy and clawback policy (for executives) enhance alignment and accountability frameworks .
    • Clear director compensation structure; Brown’s cash fees align with Audit Chair schedule ($40,000 director + $15,000 Audit Chair = $55,000) and annual RSU grants consistent with policy .
  • Potential conflicts/monitoring points:

    • Aon dual roles (comp consultant and D&O broker). Independence evaluated and no conflict found; D&O brokerage engagement was management‑recommended and Board‑approved—appropriate disclosure but worth monitoring for ongoing independence .
    • Director ownership guidelines exist but numeric thresholds not disclosed in proxy—cannot assess compliance versus guidelines from the filing alone .
  • Signals affecting investor confidence:

    • Reclassification of director classes (including Brown to Class I) was administrative to equalize classes; service deemed uninterrupted—no governance dispute implied .
    • Audit Committee’s 2024 report and recommendation to include audited financials in 10‑K supports effective oversight .
    • Section 16(a) compliance note did not include Brown among delayed filers for 2024, supporting compliance .

Fixed Compensation Details (Policy Reference)

ComponentAmount ($)Notes
Director annual fee (non‑Chair)40,000 Quarterly in arrears; prorated if partial service
Audit Committee Chair15,000 Brown is Audit Chair
Annual RSU grant (2024)9,826 RSUs Vest in single installment (day before next annual meeting or first anniversary)
RSU grant fair value (2024)129,998 ASC 718 grant‑date fair value

Other Governance Disclosures

  • Executive sessions: Non‑management director sessions regularly held; at least twice per year independent directors meet privately; presided by the independent Chair or Lead Director as applicable .
  • Say‑on‑Pay: First advisory vote held in 2025; Board recommended FOR and annual frequency .
  • Related‑party transaction policy: Audit Committee approves/ratifies transactions per Item 404; directors with interests recuse; policy summarized in proxy .

RED FLAGS

  • Consultant dual engagement (Aon) could pose perceived conflict risk; mitigated by independence assessment and disclosure, but monitor future engagements and fee arrangements .
  • No explicit pledging prohibition disclosed in proxy; hedging prohibited—investors may prefer explicit anti‑pledging policy clarity .
Overall, Brown’s independent status, audit leadership, financial expertise, and attendance underpin board effectiveness; disclosures on consultant independence and anti‑hedging/clawback policies support governance alignment. Continued monitoring of consultant roles and disclosure of director ownership guideline thresholds would further strengthen investor confidence. **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:29]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:30]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:32]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:31]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:37]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:20]**